Genetic interaction networks are a powerful approach for functional genomics, and the synthetic lethal interactions that comprise these networks offer a compelling strategy for identifying candidate cancer targets. As the number of published shRNA and CRISPR perturbation screens in cancer cell lines expands, there is an opportunity for integrative analysis that goes further than pairwise synthetic lethality and discovers genetic vulnerabilities of related sets of cell lines. We re-analyze over 100 high-quality, genomescale shRNA screens in human cancer cell lines and derive a quantitative fitness score for each gene that accurately reflects genotype-specific gene essentiality. We identify pairs of genes with correlated essentiality profiles and merge them into a cancer coessentiality network, where shared patterns of genetic vulnerability in cell lines give rise to clusters of functionally related genes in the network. Network clustering discriminates among all three defined subtypes of breast cancer cell lines (basal, luminal,, and further identifies novel subsets of Her2+ and ovarian cancer cells. We demonstrate the utility of the network as a platform for both hypothesis-driven and data-driven discovery of context-specific essential genes and their associated biomarkers.
Introduction
The concept of synthetic lethality, where one gene becomes essential in the presence of a second gene's mutation or loss of function, has long been recognized as a powerful strategy to finding candidate therapeutic targets for cancer [1] . Recently, several promising leads for chemotherapeutic targeting were discovered by identifying likely synthetic lethal gene pairs where one member of the pair is frequently co-deleted alongside a neighboring tumor suppressor gene -an approach called collateral lethality [2] . In glioblastoma, for example, the glycolytic gene enolase 1 (ENO1) is frequently deleted, rendering those cells specifically dependent on the gene's homologue, ENO2 [2] .
Similarly, in pancreatic cancer, malic enzyme 2 (ME2), which converts malate to pyruvate in the mitochondria, imparts a selective dependency on its paralog ME3 when ME2 is codeleted with tumor suppressor SMAD4 [3] .
The best known clinical application of synthetic lethality is the emergent sensitivity to PARP inhibitors discovered in BRCA1 and BRCA2 mutant cells [4] [5] [6] . The FDA has recently expanded the clinical application of the PARP inhibitor olaparib beyond BRCA1/2-mutant ovarian cancer to patients with BRCA1/2 or ATM-mutated advanced prostate cancer. The addition of ATM-mutant backgrounds is the result of an important trend in preclinical research regarding olaparib inhibitor efficacy: tumors (and cell lines) deficient in any of several components of the homologous recombination (HR) mediated DNA double strand break repair machinery are highly dependent on alternative repair pathways mediated by PARP [7, 8] . Mutations in more than a dozen genes involved in HR and other DNA damage response pathways are also associated with reliance on PARP and, in turn, increased sensitivity to olaparib [9, 10] .
Several genetic screening approaches are currently underway to systematically define the network of synthetic lethal relationships in human cells, in order to refine our knowledge of functional genomics and to exploit specific interactions for cancer targeting. Digenic knockout screens in human cells using dual-gRNA CRISPR/Cas9 constructs have demonstrated the potential of targeted pairwise gene knockout screens [11, 12] , but scalability is a major issue and technology advances will be required before this strategy can be employed on a genomic scale.
A second approach, whole-genome screens across a panel of isogenic "query gene" knockout cell lines, offers considerable advantages for functional genomics: a single, genome-scale perturbation library can be developed and re-used across a large number of experiments, allowing relatively easy data integration. This approach has been used with great success in yeast: a massive survey of 23 million double mutants defined a global map of genetic interactions [13, 14] and demonstrated that genes with correlated genetic interaction profiles across a panel of query strains were often involved in the same biological processes, enabling functional characterization of previously uncharacterized genes. Such a strategy holds great promise for human functional genomics studies but may be less applicable for cancer targeting, as tumor-relevant synthetic lethals are often context dependent and not generalizable from isogenic screens [10, 12, 15] . Indeed the dynamics of genetic interaction networks are also an area of active research [16, 17] .
The third strategy involves genome-scale perturbation screens across a large panel of genetically diverse cancer cell lines. The integrated analysis of such data would reveal genes that are consistently essential across similar cell lines (e.g. those sharing a common driver oncogene), helping to address the generalizability issue in isogenic screens [18] . It would aid the identification of genetic vulnerabilities that are specific to a given genetic background or subtype by demonstrating their nonessentiality outside of that subtype.
Also, such a study would carry its own internal controls, as functionally related genes should show correlated patterns of essentiality across sufficiently diverse backgrounds.
In this study, we describe the integrated analysis of a large compendium of genetic perturbation screens. Using over 100 genome-scale, pooled-library shRNA screens from breast [19] , ovarian [20] , and pancreatic [21] cancer cell lines, all conducted with a common shRNA library and using similar experimental designs, we show that optimizing for co-functionality reveals a gene coessentiality network whose structure is driven by the shared genetic vulnerabilities of the cell lines. We demonstrate that clusters of coessential genes define known as well as novel subgroups of cell lines, and show how the network can be integrated with tumor molecular data to predict known and novel drug targets and their biomarkers. This approach demonstrates how the integrated analysis of noisy cell line screens can be used for hypothesis-driven as well as data-driven discovery.
Results

Generating the coessentiality network
A fundamental insight from the systematic survey of genetic interactions in yeast is that if two genes have similar interaction profiles across the same panel of genetic backgrounds, they are likely to be involved in the same biological process [22] . We reasoned that an analogous principle should hold in human cell lines: that a gene's perturbation-induced fitness defect likely varies across different genetic backgrounds, yielding a gene "essentiality profile," and that genes with correlated essentiality profiles ("coessential genes") should be involved in the same cellular functions. We hypothesized that, given a high-quality set of perturbation fitness screens across a sufficiently diverse set of tumor genetic backgrounds and tissues of origin, patterns of covariation in essentiality profiles that correspond to known tissues or subtypes might reveal new context-specific essential genes that could potentially serve as novel therapeutic targets. Moreover, we reasoned that the cell lines driving these patterns of covariation might reveal novel genetic or phenotypic subtypes based on shared genetic vulnerabilities.
To this end, we re-analyzed a set of genome-scale pooled library shRNA screens in human cell lines [19] [20] [21] . All the screens were conducted with an shRNA library containing Genes with highly correlated essentiality profiles in this filtered data set showed nearly 30-fold enrichment for involvement in the same biological process, validating our hypothesis that human essentiality profiles are analogous to yeast genetic interaction profiles (Figure 1b, red) . Hereafter, we refer to each gene's hairpin-and quantilenormalized Bayes Factor in this matrix as its essentiality score, where an essentiality score > 2 is considered a high-confidence hit.
We then merged the gene pairs with the highest correlations (adjusted P-value < 0.001, Table 5 ). We clustered the network using mcl [25] , an implementation of Markov clustering, and observed that many clusters showed high functional coherence, as would be expected from a network trained on maximizing the presence of co-functional gene pairs. In particular, the ribosome and proteasome appeared in distinct clusters in the coessentiality network (Figure 1d , red and purple clusters; Supplementary Table 6 ).
Clusters in the coessentiality network are defined by distinct cell types
Though the presence of functionally coherent clusters serves as a useful positive control for our approach, our motivating hypothesis was that other clusters of coessential genes might reveal subtype-specific patterns of genetic vulnerability. Indeed, one of the largest clusters in the network contained well-characterized oncogenes CCND1, CDK4, and FOXA1, known to be specific to breast cancers of luminal subtype ( Figure 1d , dark blue).
We extracted the 29 genes in this cluster from the essentiality matrix and performed [26] . A recent report indicates that dependency on αKGDH is driven by PIK3CA mutations [27] . However, the differential sensitivity to perturbation in our network is not correlated with PIK3CA Complex I is gaining attention as a candidate therapeutic target in cancer, in particular as a target of the widely prescribed antidiabetic drug metformin [28, 29] . Identifying a biomarker of Complex I sensitivity could have major clinical relevance. To explore whether our observed difference in phenotype among similar cancer cell lines might reflect some identifiable molecular difference in tumors, we searched for functional phenotypes or biomarkers that might segregate the cell lines. Surprisingly, we found no significant functional enrichment among differentially expressed genes (Supplementary Table 6 ), including no difference among gene sets related to oxidative phosphorylation or mitochondrial function. A subsequent analysis based on genomic coordinates of differentially expressed genes did, however, reveal several loci that are candidates for copy number aberrations (Supplementary Table 7 ). In particular, genes located at 5q14-22 show significantly lower expression in the oxphos-sensitive cells, suggesting a genomic copy loss at that locus (Figure 3c ). In TCGA data from ovarian tumors [30, 31] , tumors with a heterozygous or homozygous copy loss at this locus show a significant increase in median survival, especially for tumors of the mesenchymal subtype (41 vs. 31 months; P=0.039, log-rank test; Figure 3d ). The survival difference appears to be limited to the mesenchymal subtype: including all ovarian tumors (n=481) improves the P-value (P=0.0049) but reduces the median survival difference to 2.5 months, while no difference is indicated for proliferative (P=0.12), immunoreactive (P=0.82), or fallopian subtypes (P=0.85). This example highlights an indirect approach to discovering tumor subtypes of potential clinical relevance: identifying phenotypic differences between groups of cell lines, finding biomarkers that segregate those phenotypes, and applying those biomarkers to primary tumor data.
Core essentials are more sensitive to perturbation at lower expression levels
The matrix of gene essentiality scores holds utility beyond the correlation network described. We examined the relationship between gene expression and essentiality by calculating the Pearson correlation coefficient between a gene's essentiality profile and its expression profile across the same samples. Across the 2,883 essential genes in the final data set, the distribution of correlation coefficients is roughly normally distributed and centered at zero (Figure 4a ), indicating no general relationship between variation in expression and variation in essentiality. However, we observed two notable exceptions to this general trend. First, "core essential" genes-genes expected to be essential across all cell lines [32] -show a strong bias toward negative correlation, indicating that lower expression implies a greater sensitivity to perturbation (Figure 4a , orange curve). This is broadly consistent with studies of variation in gene expression across C. elegans strains [33] as well as the increasing body of work suggesting heterozygous copy loss of core essential genes in cancer cells-and the commensurate lower gene expressionincreases sensitivity to drugs targeting those genes and pathways [2, [34] [35] [36] . Second, at the other end of the spectrum, genes with highly positive expression/essentiality correlation tend to be tissue-specific essential genes. Of the nine genes with correlation coefficient >= 0.4 (Figure 4a, inset) , all showed a strong tendency toward essentiality in a specific subtype, including previously mentioned SPDEF and FOXA1 in luminal-subtype breast cancer cells, ERBB2 and estrogen receptor gene ESR1 in Her2+ and luminalsubtype cells, respectively, and FUBP1 and PAX8 in ovarian cancer cells.
EXO1 depletion sensitizes OV/ECC cells to MDM2 inhibition
We expected that the expression-dependent essentiality of MDM2, a gene whose major role in cancer is the suppression of P53 protein expression, would be associated with subtypes that are not characterized by genetic suppression of pro-apoptotic TP53 activity, e.g. by mutation, deletion, or methylation. We found this to be true for BrCa/luminal cell lines (P=0.015; Fisher's exact test) but, surprisingly, not true for ovarian cancer cell lines, where endometrioid and clear cell subtypes are often characterized by wildtype TP53 (P=0.454; Figure 4b ).
To explore the possibility that these cells rely on different DNA damage response pathways, we compared the essentiality scores in ovarian cancer cell lines with (n=21) and without (n=7) TP53 mutations, after excluding 7 cases with low TP53 mRNA expression ( Figure 4C ). The top hit was EXO1, an exonuclease involved in DNA mismatch repair and double strand break repair [37, 38] . While P53wt and P53mut ovarian cancer cell lines showed a marked difference in sensitivity to perturbation of EXO1 by shRNA (P=3.9x10 -7 , t-test; Figure 4c , inset), it is worth noting that even the EXO1-sensitive lines did not meet our threshold of high-confidence hits (essentiality score >=2). This is consistent with the fact that CRISPR-mediated EXO1 knockout in P53wt cells did not elicit a severe fitness defect (Figure 4d ). However, EXO1 deletion did restore sensitivity to MDM2 inhibition: EXO1 null P53wt cells are more sensitive to MDM2 inhibitor nutlin-3a than their EXO1 wt parental strains (Figure 4e ), supporting the existence of a synthetic interaction between p53 mutation state and EXO1 in this cell type and further confirming the utility of the coessentiality network to identify novel context-specific genetic interactions.
Discussion
A key insight from the systematic survey of yeast genetic interactions is that genes which operate in the same biological processes tend to have similar profiles of genetic interactions across a diverse panel of query strains; that is, they show the same patterns of fitness defects across different genetic backgrounds. We applied this concept to the analysis of genetic perturbation screens in human cell lines, using the BAGEL-derived Bayes Factor as a fitness score. Initially, the approach did not appear to work, as correlated gene fitness profiles showed no enrichment for co-functionality. However, after filtering the data to include only high-quality screens and high-confidence essential genes, the picture came into focus, with highly correlated genes showing nearly thirtyfold enrichment for shared biological process annotations. This preliminary result further illustrates the value of the BAGEL algorithm in offering a semi-quantitative measure of gene knockdown fitness as well as the utility of the approach outlined in [32] to distinguish high quality screens from those that should be removed from downstream analyses.
We combined the highly correlated gene pairs into a network of genes, where genes are connected by an edge if they show a correlated fitness profile across the panel of 112 cell lines. Clustering this network revealed groups of genes, some of which operate in wellannotated biological pathways-e.g. the ribosome and proteasome clusters-while other genes were grouped together based on patterns of covariation in fitness across the different cellular contexts included in the network. Clusters identifying genes specifically essential in luminal and Her2-amplified breast cancer cell lines, for example, were readily identified in the network, validating our approach. Furthermore, among the novel clusters was a large cluster of genes related to mitochondrial function that segregate ovarian cancer cell lines into oxphos-sensitive and oxphos-resistant classes. This latter group shows a molecular signature represented by chromosomal copy loss in the 5q14-22 region that, in turn, offers a survival advantage for ovarian cancer patients. Thus, the coessentiality network offers a method of identifying both novel differentially essential genes across known subtypes but also a way to discover new subtypes, with possible clinical relevance, from a large body of shRNA knockdown data.
The matrix of essentiality scores we generated offers utility beyond the network approaches described. We measured the correlation between these normalized fitness scores and mRNA expression levels of the same gene, which revealed three distinct subgroups. Tissues-specific essentials show high expression/fitness correlation but are rare among the subtypes that were assayed here. Core essentials, in contrast, showed an increasing sensitivity to perturbation at lower expression levels. This is generally consistent with the concept of genomic copy loss of essential genes leading to a possible therapeutic window for drug targeting, and extends the pool of candidate targets to include all core essential genes (i.e. those essential in virtually all backgrounds). Finally, the bulk of the signal is that there is no signal: in general essential genes showed no correlation between their expression level and their knockdown fitness. This has 
Methods
Primary data processing
Data from shRNA screens in pancreatic, ovarian, and breast cancer cell lines was downloaded from the Donnelly-Princess Margaret Screening Centre (formerly COLT [43] ) at dpsc.ccbr.utoronto.ca. The shRNA and RNA-seq data are from three published studies of shRNA screens [19] [20] [21] .
Each screen consists of a reference timepoint (T0) and one to two experimental timepoints (T1, T2), typically assayed in triplicate using custom microarrays. See [21] for experimental details. shRNA hairpins (hereafter 'hairpins') are retained if log2 intensity at the T0 timepoint was > 9. Fold-changes were calculated independently for each replicate at each timepoint, and a Bayes Factor was calculated using BAGEL [32] on all replicates at each timepoint. Bayes Factors are summed across timepoints for a final gene-level Bayes Factor for each cell line.
In parallel, RNA-seq on each cell line was processed using Tophat v2 [44] and Cufflinks v2 [45] To maximize functional enrichment, three normalization and filtering methods were applied. First, each Bayes Factor for each gene in each cell line was divided by the number of hairpins used to calculate the BF. Second, the matrix of hairpin-normalized BFs was quantile normalized. This hairpin-and quantile-normalized BF is referred to as the "essentiality score". Third, a gene was only retained for downstream analysis if it had an essentiality score > 2 (corresponding to ~15% FDR) in at least two cell lines where the gene was also expressed at above modal expression. The filtered gene set includes 2,883 genes.
To create the coessentiality network, the mcl clustering algorithm was applied to sets of highly correlated genes using a sampling strategy across three parameters. First, correlation thresholds of 0.1%, 0.2%, 0.5%, and 1.0% FDR were applied (n=1,568, n=2,240, n=3,684, n=5,690 gene pairs respectively). Second, native correlations or correlations raised to the 4 th power were considered. Third, the -I parameter of mcl was applied in a range from 1.8 to 4.1 in 0.1 increments.
The output from mcl is a list of hard clusters (each gene is assigned to exactly one cluster). The functional enrichment of each mcl run output was evaluated using the same process as functional enrichment of the essentiality score correlations, but considering whether co-clustered genes were also enriched for co-functionality. The data set using correlations at FDR 0.1%, raised to the 4 th power, and with mcl -I 2.0 was judged to have the best combination of coverage and functional enrichment; this subset of correlations comprises the Cancer Coessentiality Network v1.0 (Supplementary Table 5 ) and the mcl output defines the clusters described in this study (Supplementary Table 6 ).
Tumor genomic analysis
Gene-level copy number data for 481 ovarian tumors from [30] was downloaded from cBioPortal [31] . Mean log2 copy number across all genes in the 5q14-22 locus was calculated and samples were divided into "copy loss" (mean copy number < -0.5) and "no copy loss" (mean copy number > -0.5). Kaplan-Meier survival analysis was performed using the lifelines package in Python v 2.7. Table 9 Cell lines were selected based on their tissue subtypes, distribution in the cluster heatmap (Figure 3a) , as well as the growth conditions. The representative cell lines of cluster that predicted high sensitivity to OXPHOS perturbation include five ovarian (OV1369, OV90neo, TOV1369TR, TOV1946 and TOV21G) and three breast (BT20, HCC1419 and SKBR5) cancer cell lines. The representative cell lines that are predicted to be less sensitive to OXPHOS perturbation include ten ovarian (ES2, JHOC5, OVCAR5, OVCAR8, PEA1, PEA2, PEO4, PEO6, PEO14 and SKOV3), one breast (MCF7) and two pancreatic (GP3A and MIAPACA2) cancer cell lines.
To normalize for media-specific effects on cell proliferation, all cell lines were cultured in the same growth media as in the pooled shRNA screens from which the Cancer Coessentiality Network was derived (see [21] ).
Rotenone sensitivity assays. Each cell line was plated into 15-cm culture plates (Corning, 430599) and was grown to 80% confluence in the requisite medium. Cells were washed with warm Dulbecco's phosphate-buffered saline (DPBS) (Gibco, 14190-144), treated with 0.25% trypsin-EDTA solution (Gibco, 25200-056) for five to ten minutes or until they lift off at 37°C, re-suspended in warm medium and counted using the Beckman Z2
Coulter Counter with a size gate setting between 10.00μm and 27.85μm. Cells were plated in ten 6-well plates (Corning, 3516) at ~200,000 cells per well, in a total volume of 3mL per well. After 24 hours, the medium was replaced with 3mL of fresh medium containing 
